Go to Top

News

News

FDA clears IV catheter system

Plastic News

A new IV catheter system designed to minimize the risk of needle-stick injuries and occupational exposure to blood has received market clearance from the Food and Drug Administration.

Tangent Shows Off NovaCath Secure IV Catheter

medGadget.com

Tangent Medical out of Ann Arbor, MI recently unveiled its NovaCath Secure IV Catheter System, a device designed to improve peripheral IV catheter stabilization and reduce the potential for clinicians being exposed to patient blood.

People & achievements in the greater Ann Arbor area

AnnArbor.com

Ann Arbor-based Tangent Medical, a developer and provider of IV therapy products, on April 12 announced submission of a 510(k) for its NovaCath Secure IV Catheter System, developed from extensive clinical research of health care worker and patient needs.

Press Releases

Tangent Medical Receives CE Mark for the NovaCath Integrated IV Catheter System

ANN ARBOR, MI – May 27, 2014 – Tangent Medical (www.tangentmedical.com), an innovator of IV therapy products, announced it has received CE Mark approval for the NovaCathTM Integrated IV Catheter System. The approval demonstrates that NovaCath meets the safety, health and environmental requirements in the European Union and clears the company to introduce NovaCath throughout Europe and other countries recognizing the CE Mark.

Tangent Medical Wins Gold in the 5th Annual 2013 Golden Bridge Awards

ANN ARBOR, Michigan – October 3, 2013 – Tangent Medical (www.tangentmedical.com), an innovator in IV therapy products and creator of the NovaCath™ Integrated IV Catheter System, was awarded with Gold Status at the Golden Bridge Awards for the Healthcare Products & Services Innovation Category. Tangent Medical, along with more than 100 innovative companies across many industries was honored in San Francisco on Monday, September 30, 2013 during the 5th annual awards dinner and presentations.

Tangent Medical Wins Gold & Silver Stevie® Awards

ANN ARBOR, MI – (September 18, 2013) – Tangent Medical (www.tangentmedical.com), an innovator in IV therapy products and creator of the NovaCath™ Integrated IV Catheter System, won a Gold  Stevie® Award in the Best New Product or Service for Health & Pharmaceuticals category and a Silver Stevie® Award for Tech Innovation of the Year (organization with up to 100 employees) at the The 11th Annual American Business Awards held in San Francisco on Monday evening.

Tangent Named as Finalist in the 5th Annual 2013 Golden Bridge Awards For the Healthcare Products & Services Innovation Category

ANN ARBOR, Michigan – (August 28, 2013) – Tangent Medical (www.tangentmedical.com), an innovator in IV therapy products and creator of the NovaCath™ Integrated IV Catheter System, has been named a finalist in the Golden Bridge Awards for the Healthcare Products & Services Innovation Category. Winners will be honored in San Francisco on Monday, September 30, 2013 during the 5th annual awards dinner and presentations. As finalists in the American Business Awards, Tangent Medical will also be named the Stevie® Award Bronze, Silver or Gold winner on September 16th for two categories including the Best New Product or Service for Health & Pharmaceuticals, and Tech Innovation of the Year (organization with up to 100 employees). Both recognitions follow the launch of the company’s flagship IV catheter product, the NovaCath Integrated IV Catheter System.

Tangent Medical Announces U.S. Launch of the NovaCath™ Integrated IV Catheter System

ANN ARBOR, MI – (June 27, 2013) – Tangent Medical (www.tangentmedical.com), an innovator in IV therapy products and creator of the NovaCath™ Integrated IV Catheter System, announced today its commercial product launch and start to clinical evaluations in several healthcare facilities across the U.S. The commercialization of this product is the first significant advancement in the IV catheter market in more than a decade.

Tangent Medical Participates in Expert Panel Discussion at 18th Annual Medical Devices 2013: A Frost & Sullivan Executive MindXchange

ANN ARBOR, MI – (March 11, 2013) – Tangent Medical Technologies (www.tangentmedical.com), an innovator in IV therapy products and creator of the NovaCath™ Integrated IV Catheter System, announced its participation as a panelist at this year’s 18th Annual Medical Devices 2013 Frost & Sullivan Executive Conference at the Hilton San Diego. Tangent Medical Vice President of Sales & Marketing Curtis Bloch is one of five expert panelists for the session: Ask the Experts! Savvy Partnering for Innovation.

Tangent Medical to Attend 2012 INS Annual Convention & Industrial Exhibition

Tangent Medical, an innovator in IV therapy products, today announced its participation (Booth # 329) at the 2012 INS Annual Convention & Industrial Exhibition on April 30 – May 2, 2012 at the Rio Hotel in Las Vegas. The NovaCath™ Secure IV Catheter System, currently under 510(k) review with the FDA, will be unveiled to the public for the first time at this convention. NovaCath is a next-generation technology designed to address current IV therapy challenges including catheter stabilization, occupational exposure to blood, tubing management and patient comfort.

Tangent Medical Submits FDA 510(k) For NovaCath™ Secure IV Catheter System

Tangent Medical, an innovator in IV therapy products, today announced submission of a 510(k) for its NovaCath™ Secure IV Catheter System, developed from extensive clinical research of healthcare worker and patient needs. This new closed IV catheter system is a next-generation technology designed to address several complex IV therapy challenges including catheter stabilization, occupational exposure to blood, and patient discomfort. When cleared by the FDA, the NovaCath™ system will be the first safety IV catheter offering advanced catheter stabilization technology designed to exceed the highest CDC, OSHA, and INS standards for peripheral IV catheter stabilization.

Tangent Medical Closes $4.5 Million Series A Financing

Tangent Medical Technologies, Inc., a development stage medical device company, announced the completion of a $4.5 million Series A equity financing co-led by Arboretum Ventures (Ann Arbor, MI) and Flagship Ventures (Cambridge, MA). Also participating in the financing were Osage Ventures and several angel investors responsible for the initial seed funding for the company. In conjunction with the financing, Tim Petersen of Arboretum and Harry Wilcox of Flagship have joined Tangent’s board of directors.

Leave a Reply